P76 Amélioration de l’équilibre glycémique grâce au GlucoDay® chez les diabétiques de type 1 et de type 2. L’étude multicentrique randomisée française

Cosson, E.; Hamo-Tchatchouang, E.; Dufaitre-Patouraux, L.; Altman, Jean-Jacques; Attali, J. R.; Schaepelynck-Bélicar, P.

doi:10.1016/s1262-3636(08)72988-4

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The analysis demonstrates that patients who utilize professional CGM more than one time per year see both a clinical benefit and an economic impact. The magnitude of the A1C result is consistent with the published literature regarding professional CGM [6][7][8][9][10] . The difference in costs could be explained by individual patient selection of points of care (e.g.…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data

Sierra

Shah

Gill

et al. 2017

Journal of Medical Economics

View full text Add to dashboard Cite

Significant clinical benefits were observed for patients who used professional CGM. Economic benefits were observed for patients who utilized professional CGM more than once within a 1-year period or who used it during a change of diabetes therapy. This suggests that professional CGM may help decrease rising trends in healthcare costs for people with type 2 diabetes, while also improving clinical outcomes.

show abstract

Section: Discussionsupporting

confidence: 89%

“…The use of professional CGM has shown to improve hemoglobin A1C (A1C), a blood test reflecting the mean glucose over the previous 2-3 months, in people with both type 1 and type 2 diabetes [5][6][7][8][9] . Currently, there is a paucity of evidence about the economic impact of this device and procedure.…”

Section: Introductionmentioning

confidence: 99%